P939: SYNERGISTIC EFFECTS OF LOW DOSE BELANTAMAB MAFODOTIN IN COMBINATION WITH A GAMMA-SECRETASE INHIBITOR (NIROGACESTAT) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-5 STUDY
P939:低剂量贝兰他单抗与γ-分泌酶抑制剂(尼罗加司他)联合治疗复发/难治性多发性骨髓瘤(RRMM)患者的协同作用:DREAMM-5研究
期刊:Canadian Journal of Kidney Health and Disease
影响因子:1.5
doi:10.1177/20543581221106244
Czikk, Daniel; Parpia, Yasin; Roberts, Katelyn; Jain, Gaurav; Vu, Dan-Cung; Zimmerman, Deborah; Fowler, S; McLaughlin, L; Bridges, S; Robichaud, M; Ridgway, B; Reece, D; Song, K; Dalrymple, L; Sully, R; Nason, S; Rowland, S; MacDonald, T; Paine, W; Reiman, A; Nooka, A; Lonial, S; Grosicki, S; Hus, M; Song, K; Facon, T; Callander, N S; Ribrag, V; Uttervall, K; Quach, H; Vorobyev, V; Min, C-K; Cheng, S; Smith, L M; Yu, J; Collingwood, T; Holkova, B; Kremer, B E; Gupta, I V; Richardson, P G; Minnema, M C